Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Approved for use in oncology care according to FDA-approved indications.
Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), relapsed or refractory Ph+ CML, gastrointestinal stromal tumors (GIST), and hypereosinophilic syndrome.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.
Approved for use in oncology care according to FDA-approved indications.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.